Skip to content
Descubridor Institucional UMAR
Inicio
Búsqueda avanzada
Explorar
Inicio
Búsqueda avanzada
Explorar
Login
Language
English
Deutsch
Español
Français
Italiano
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Using AI-MIDD for Mechanistic Model of Aspirin Linking COX-1 Acetylation, TXB₂ Turnover, and Resolvin Pathways.
Using AI-MIDD for Mechanistic Model of Aspirin Linking COX-1 Acetylation, TXB₂ Turnover, and Resolvin Pathways.
Fuente:
Zenodo
Saved in:
Bibliographic Details
Main Author:
Goryanin, Igor
Format:
Recurso digital
Published:
Zenodo
2025
Subjects:
Aspirin, COX-1 acetylation, Thromboxane B₂, Pharmacokinetic–Pharmacodynamic modeling, SBML, Quantitative systems pharmacology, Resolvin D1
Online Access:
Acceder al recurso
Tags:
Add Tag
No Tags, Be the first to tag this record!
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Save to List
Permanent link
Holdings
Description
Comments
Similar Items
Staff View
Internet
https://doi.org/10.5281/zenodo.17672989
Similar Items
The role of Pharmacokinetics in drug development
by: Sandhya, Kalthuri, et al.
Published: (2025)
Pharmacogenomics: Personalized Medicine in Pain Management
by: Farhan Khan*, Kasim Bhuriwale, Adil Shah Bad Shah, Dr. Shivshankar Mhaske, Satish Lodhe
Published: (2025)
Pharmacokinetics and pharmacodynamics of the new oral anticoagulants
by: Juan Pablo Ordovás Baines
Published: (2009)
Antibiotic Therapy in the Acute Phase of Severe Burn Injury: A Critical Review of the Literature and Proposal of an Updated Decision-Making Algorithm (2009–2025)
by: A. Hajjar, et al.
Published: (2026)
The Novel Aspirin as Breakthrough Drug for COVID-19: A Narrative Review
by: Bamidele Johnson Alegbeleye
Published: (2020)